The research & development by business enterprise, pharmaceutical industry in constant ppp $ in Austria has reached 477.88 million, signifying a 115.34 million (31.8%) increase compared to 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Austria
No matching regions
Similar regions to Austria
Business R&D pharmaceutical in constant PPP $
More indicators for Austria
Government R&D in security as % of government support
0.1%
-0.01%
(2021)
Higher-education-finacing R&D financed by general university in local currency
19,572.37M
+2,020.17M
(2021)
R&D financed by rest of the world in local currency
23,925.50M
+1,142.33M
(2022)
Government R&D financed by rest of the world in local currency
893.92M
+42.59M
(2021)
Business R&D financed by rest of the world in local currency
19,659.92M
+1,314.42M
(2021)
Non-profit R&D growth rate
2.78%
+7.47%
(2022)
Austria Business R&D pharmaceutical in constant PPP $ between 1998 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 477.88M | +115.34M |
| 2020 | 362.54M | +30.02M |
| 2019 | 332.52M | -12.80M |
| 2018 | 345.32M | -32.69M |
| 2017 | 378.01M | -5.37M |
| 2016 | 383.38M | +15.38M |
| 2015 | 368.00M | -16.83M |
| 2014 | 384.83M | +12.33M |
| 2013 | 372.50M | +54.62M |
| 2012 | 317.87M | +86.76M |
| 2011 | 231.12M | -0.13M |
| 2010 | 231.25M | -37.14M |
| 2009 | 268.39M | -91.26M |
| 2008 | 359.65M | -46.01M |
| 2007 | 405.66M | -4.64M |
| 2006 | 410.30M | +51.51M |
| 2005 | 358.80M | +104.19M |
| 2004 | 254.61M | +31.29M |
| 2003 | 223.32M | -4.38M |
| 2002 | 227.70M | +1.03M |
| 2001 | 226.67M | +3.53M |
| 2000 | 223.14M | +9.78M |
| 1999 | 213.36M | +10.10M |
| 1998 | 203.26M |